CHOROIDAL NEOVASCULARISATION

This adverse event was reported 858 times

These drugs are most commonly taken by patients reporting CHOROIDAL NEOVASCULARISATION:

# Drug Count
0 RANIBIZUMAB 359
1 VERTEPORFIN FOR INJECTION 99
2 AFLIBERCEPT 89
3 BEVACIZUMAB 70
4 PEGCETACOPLAN 65
5 PREDNISOLONE 19
6 PREDNISOLONE ORAL 19
7 PREDNISOLONE ORAL SOLUTION 19
8 TROPICAMIDE 19
9 ASPIRIN 18
See all common drugs associated with CHOROIDAL NEOVASCULARISATION

CHOROIDAL NEOVASCULARISATION is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 VERTEPORFIN FOR INJECTION 99 0.0668
1 PEGCETACOPLAN 65 0.0342
2 INDOCYANINE GREEN 4 0.0331
3 RANIBIZUMAB 359 0.0136
4 PYCNOGENOL 6X 1 0.0116
5 TROPICAMIDE 19 0.0116
6 TETRACAINE 3 0.0076
7 PROPARACAINE HYDROCHLORIDE 4 0.0075
8 FLUORESCEIN SODIUM 2 0.0065
9 FLUORESCEIN 4 0.0064
See all drugs enriched for association with CHOROIDAL NEOVASCULARISATION

CHOROIDAL NEOVASCULARISATION is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Photoenhancer [EPC] 99 0.0255
1 Diagnostic Dye [EPC] 8 0.0124
2 alpha-1 Adrenergic Agonist [EPC] 15 0.0034
3 Vascular Endothelial Growth Factor Inhibitor [EPC] 448 0.0024
4 Antiseptic [EPC] 10 0.0023
5 Plasma Volume Expander [EPC] 4 0.0013
6 Anticholinergic [EPC] 19 0.0012
7 Complement Inhibitor [EPC] 65 0.0012
8 Gonadotropin [EPC] 2 0.0009
9 Lymphocyte Growth Factor [EPC] 1 0.0008
See all drug classes enriched for association with CHOROIDAL NEOVASCULARISATION